Jaguar health, inc. reports 2021 second quarter financial results

Second quarter 2021 mytesi ® net and gross sales were approximately $0.4 million and approximately $4.9 million company transitioning to primarily selling mytesi directly through selected specialty pharmacies as part of company's market access strategy company to host investor webcast friday, august 13th at 8:00 a.m. eastern regarding second quarter 2021 financials & business updates; webcast registration link appears below san francisco, ca / accesswire / august 13, 2021 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today reported consolidated second quarter 2021 financial results.
JAGX Ratings Summary
JAGX Quant Ranking